Femasys Corporation (FEMY): Earnings per share for the last twelve months
Femasys Inc. is implementing automated lines for the sterile production of products. The sliding net profit per share snapshot visualizes financial stability, where -4.60 reflects the latest value of the metric. However, geopolitical tensions and Asian tariffs are increasing component costs, which is offset by an organic expansion strategy through clinic partnerships without conducting mergers.
Analytical breakdowns for Femasys Inc. (FEMY)
- stock price and consensus target price:
- stock exchange capitalization data:
- shareholders' equity book value data:
- debt burden and liquidity indicators:
Debt to Equity Femasys Inc.|FEMY - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Femasys Corporation|FEMY - Company Aggregate Debts|Debt to Book Capitalization Ratio Femasys Corporation|FEMY - Company Long-Term Liabilities|Company Short-Term Debts Femasys|Quick Liquidity femasys.com
- earnings and multiples data:
FEMY - Company Profit|Future Profit Femasys Inc.|FEMY - Market Price to Net Income Ratio|Future Price to Earnings Femasys Corporation|FEMY - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Femasys Inc|FEMY - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) Femasys|FEMY - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months femasys.com|FEMY - Net earnings per share growth this year|Earnings growth forecast for next year Femasys Inc.
- total revenue and sales volume data:
Analysis of all company metrics:FEMY - Femasys Inc
Femasys Inc. monetizes the development of high-tech minimally invasive systems for gynecology. The efficiency of this model is quantified through the ratio of aggregate net income to the total number of shares. This metric measures the real return on each share of ownership, stripping profit of the impact of issuance. The trend of the rolling 12-month EPS reveals the actual viability of the business during periods of consolidation. The stability of this chart confirms the resilience of the company's operating cash flow.
Competitor analysis
Intuitive Surgical, Inc. - Net earnings per share (EPS TTM)|DHR (Danaher Corporation) - Earnings per share for the last 12 months|Becton Dickinson & Company (BDX) - Earnings per share for the last twelve months|STE - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months WST|BAX (baxter.com) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months MASI (Masimo Corporation)|Earnings per share for the last four quarters STVN|Teleflex Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year MMSI|NVST: Net earnings per share for the last 12 months|ICUI - Net earnings per share (EPS TTM)|Dentsply Sirona Inc (XRAY) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months LeMaitre Vascular|ATRC (atricure.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months STAAR Surgical Co STAA|Earnings per share for the last twelve months ChromaDex (NAGE)|ZimVie - Earnings per share for the last 12 months|AngioDynamics, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters CERS (Cerus Corp.)|TKNO - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Monogram Orthopedics Inc. MGRM|Sharps Technology, Inc. (STSS) - Earnings per share for the last twelve months|INFU - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months UTMD|Net earnings per one share for the last twelve months korumedical.com KRMD|Net earnings per share for the last 12 months NYXH (Nyxoah S.A.)|Net earnings per share for the last 12 months Microbot Medical, Inc MBOT|Pro-Dex Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ZTEK (Zentek Ltd.)|Elutia Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Milestone Scientific Corp MLSS|NEXGEL, Inc (NXGL) - Earnings per share for the last twelve months|RVP: Earnings per share for the last four quarters|HBIO (Harvard Bioscience, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months MeihuaMed (MHUA)|Net earnings per share (EPS TTM) POAI|Earnings per share for the last four quarters CJMB|Earnings per share for the last twelve months atrioncorp.com ATRI|Earnings per share for the trailing year NURO
